9.63€
+
0.39€ (4.22%)
End-of-day quote: 04/29/2024
XTRA:EVT
Evotec Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| IQV | IQVIA Holdings | NYSE | Outperform | $235.48 | $267.27 | 0.00% | 19 | $42.11B |
| IDXX | IDEXX Laboratories | NasdaqGS | Outperform | $505.34 | $583.92 | 0.00% | 0 | $39.58B |
| ICLR | ICON Public | NasdaqGS | Buy | $304.14 | $306.07 | 0.00% | 1 | $25.49B |
| ARGX | argenx | ENXTBR | Outperform | 348.50€ | 531.81€ | 0.00% | 10 | 20.03€B |
| GMAB | Genmab A/S | CPSE | Outperform | kr1.97k | kr2.71k | 0.00% | 14 | kr130.39B |
| SRT3 | Sartorius | XTRA | Outperform | 291.80€ | 281.57€ | 0.00% | 10 | 16.73€B |
| LH | Laboratory Corp of America Hol... | NYSE | Outperform | $204.17 | $241.28 | 0.00% | 9 | $16.73B |
| SGSN | SGS | SWX | Hold | CHF82.22 | CHF86.34 | 0.00% | 7 | CHF15.11B |
| DGX | Quest Diagnostics | NYSE | Outperform | $139.50 | $141.17 | 0.00% | 8 | $15.28B |
| BVI | Bureau Veritas | ENXTPA | Outperform | 27.48€ | 26.96€ | 0.00% | 12 | 12.42€B |
| MEDP | Medpace Holdings | NasdaqGS | Outperform | $400.21 | $281.20 | 0.00% | 2 | $12.29B |
| ERF | Eurofins Scientific | ENXTPA | Hold | 58.70€ | 0.00€ | 0.00% | 5 | 10.96€B |
| CRL | Charles River Laboratories Int... | NYSE | Outperform | $232.10 | $229.97 | 0.00% | 11 | $11.65B |
| REC | Recordati Industria Chimica e ... | BIT | Hold | 49.42€ | 48.61€ | 0.00% | 1 | 10.26€B |
| CTLT | Catalent | NYSE | Hold | $56.30 | $49.29 | 0.00% | 3 | $10.04B |
| ITRK | Intertek Group | LSE | Outperform | £49.36 | £44.87 | 0.00% | 14 | £7.96B |
| SHL | Sonic Healthcare | ASX | Hold | $26.76 | $34.12 | 0.00% | 0 | $13.61B |
| BANB | Bachem Holding | SWX | Hold | CHF81.20 | CHF616.00 | 0.00% | 2 | CHF6.08B |
| HIK | Hikma Pharmaceuticals PLC | LSE | Outperform | £19.30 | £28.11 | 0.00% | 9 | £4.59B |
| ABCM | Abcam | NasdaqGS | - | $23.99 | $19.25 | 0.00% | 0 | $5.52B |
| ORNBV | Orion Oyj | HLSE | Hold | 36.33€ | 42.52€ | 0.00% | 3 | 4.97€B |
| ZEAL | Zealand Pharma A/S | CPSE | Outperform | kr617.50 | kr357.00 | 0.00% | 2 | kr36.34B |
| TECN | Tecan Group | SWX | Outperform | CHF331.60 | CHF406.33 | 0.00% | 3 | CHF4.54B |
| ALK B | ALK-Abelló A/S | CPSE | Outperform | kr130.80 | kr109.25 | 0.00% | 3 | kr28.44B |
| MOR | MorphoSys | XTRA | Outperform | 65.65€ | 28.78€ | 0.00% | 3 | 2.47€B |
| SYNH | Syneos Health | NasdaqGM | - | $42.98 | $43.00 | 0.00% | 0 | $2.64B |
| GLPG | Galapagos NV | ENXTAM | Hold | 26.76€ | 39.85€ | 0.00% | 2 | 2.42€B |
| INDV | Indivior PLC | LSE | Buy | £14.63 | £28.89 | 0.00% | 4 | £1.91B |
| ALM | Almirall | BME | Outperform | 8.48€ | 11.39€ | 0.00% | 3 | 1.73€B |
| APPS | Applus Services | BME | Outperform | 12.74€ | 10.92€ | 0.00% | 3 | 1.47€B |
| CLIN | Clinigen | AIM | - | £9.25 | £7.78 | 0.00% | 0 | £1.23B |
| BIO3 | Biotest | XTRA | Hold | 28.90€ | 37.00€ | 0.00% | 0 | 1.39€B |
| VEC | Vectura Group | LSE | - | £165.00 | £1.55 | 0.00% | 0 | £1.00B |
| COPN | Cosmo Pharmaceuticals N.V. | SWX | Buy | CHF72.10 | CHF76.55 | 0.00% | 0 | CHF1.15B |
| FAE | Faes Farma | BME | Hold | 3.38€ | 3.90€ | 0.00% | 0 | 1.05€B |
| 4544 | H.U. Group Holdings | TSE | Outperform | ¥2.69k | ¥0.00 | 0.00% | 0 | ¥164.15B |
| ERGO | Ergomed | AIM | - | £9.84 | £14.90 | 0.00% | 0 | £490.82M |
| PHM | Pharma Mar | BME | Outperform | 29.82€ | 50.20€ | 0.00% | 1 | 510.85€M |
| BSLN | Basilea Pharmaceutica | SWX | Outperform | CHF40.20 | CHF65.63 | 0.00% | 0 | CHF448.11M |
| NIOX | NIOX Group Plc | AIM | Buy | £0.70 | £0.76 | 0.00% | 0 | £246.03M |
| DBV | DBV Technologies | ENXTPA | Outperform | 1.24€ | 4.07€ | 0.00% | 1 | 119.30€M |
| MOLN | Molecular Partners | SWX | Outperform | CHF3.19 | CHF9.50 | 0.00% | 1 | CHF110.77M |
